Chemours

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemours overcomes Q4 challenges, eyes growth and sustainability in 2023

Chemours had a tough Q4 but a successful year overall, with a focus on margin improvement, growth in key businesses, and addressing legacy issues. The company is optimistic about 2023, emphasizing sustainability-led growth and returning value to shareholders.

Chemours reports strong Q1 performance, navigates challenges, eyes growth opportunities

Chemours' Q1 2023 Earnings Call highlighted strong performance, reaffirmed guidance, and emphasized margin improvement strategies. The company faces challenges from macroeconomic uncertainties and inflationary pressures but sees opportunities in sustainable initiatives and market-led innovation. Chemours remains confident in its full-year outlook and growth strategies.

Chemours reports record results, eyes cost reduction and innovation

Chemours had a strong quarter with record results and notable achievements in facility closures and settlements. While challenges lie ahead with a weaker second half expected, the company remains focused on shareholder value and strategic priorities. Opportunities in cost reduction, innovation, and market leadership position Chemours for future growth.

Chemours addresses challenges, eyes growth in sustainable solutions market

Chemours Company navigated challenges in Q3 2023, with a focus on long-term shareholder value and strategic transformation for performance improvement.
Strong performance in Performance Solutions and TSS business, alongside cost savings initiatives, position Chemours for future growth and margin recovery.
Management's commitment to driving value for shareholders amidst industry challenges underscores a proactive approach to addressing market dynamics.

Chemours reports Q4 sales growth, addresses TiO2 market challenges

Chemours is navigating challenges in the TiO2 market while focusing on cost reduction and growth opportunities in other segments. The company aims to maintain competitiveness through strategic decisions and investments in R&D. Analysts' inquiries during the earnings call highlighted concerns about leadership stability and various segment dynamics.

Chemours reports mixed Q1 results, eyes sequential growth in 2024

Chemours' Q1 2024 performance reflected mixed results across segments, with a focus on cost efficiencies, transformation plans, and maintaining liquidity amidst declining net sales and EBITDA.
Despite challenges in certain segments and market uncertainties, Chemours remains optimistic about sequential growth in the second quarter, aiming for significant EBITDA potential in 2024 and long-term financial improvement.
Strategic strengths in cost management, growth initiatives, and market opportunities position Chemours to navigate challenges, drive growth, and enhance profitability in a dynamic business environment.

Chemours exceeds volume expectations amidst challenges, anticipates sequential decline

Chemours demonstrated resilience and growth in key product lines despite facing challenges in Q1 and Q2.
The company's cost-saving efforts and recovery in certain segments highlight its ability to adapt to market conditions.
While financial results were impacted by one-time costs and a decline in net sales, Chemours maintained a strong net leverage ratio.
Anticipated sequential decline in net sales for Q3 underscores the need for strategic planning and operational optimization.

Chemours reports strong Q3 performance amidst strategic growth initiatives

Chemours' Q3 performance reflects operational strength and growth in key segments.
Challenges include declines in net sales for TSS and TT in Q4 and a net loss.
Opportunities exist in cost savings, growth in Opteon refrigerants, and strategic investments.
Overall, Chemours remains confident in its strategy to drive shareholder value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Chemours (CC) Could Beat Earnings Estimates Again

Air Liquide SA

Amazon

Bloom Energy

CNX Resources

Chevron

Dominion Energy

Marathon Petroleum

Nikola

Plug Power

Rockwell Automation

Walmart

Xcel Energy

Exxon Mobil

The US Department of Energy finally decided who would get a piece of the $7 billion Federal funding for green hydrogen, and the news may surprise you. The funding is intended to build green hydrogen infrastructure, but the terminology would be more suitable if it read “greener” hydrogen.

$7 Billion in Clean Hydrogen Grants: Winners and Losers

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call.

Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call

WestRock

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

These 3 Materials Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts - Chemours (NYSE:CC), FMC (NYSE:FMC)

Chemours (CC) gains on strong execution, continued Opteon adoption and its efforts to reduce costs amid headwinds from demand weakness.

Here's Why You Should Hold Onto Chemours (CC) Stock For Now

U.S. chemical company Chemours CC.N is liable for environmental damage in the Netherlands caused by PFAS chemicals, the Rotterdam District Court ruled on Wednesday.

Dutch court rules Chemours liable for environmental damage caused by PFAS

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Promotion of Ron Charles to Senior Vice President of the People Function, as Susan Kelliher Announces Retirement.

Chemours Announces Promotion of Ron Charles to Senior Vice President of the People Function, as Susan Kelliher Announces Retirement

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the winners of its third annual Carrier of the Year Award which recognizes excellence in the transportation of Ti-Pure™ titanium dioxide (TiO2) to Chemours customers. Marten Transport (Platinum award) and Hirschbach Transportation Services (Gold.

Chemours Titanium Technologies Announces Third Annual Carrier of the Year Award

Although Chemours (CC) is being challenged by softer demand in certain businesses, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.

Chemours (CC) Benefits From Opteon Adoption Amid Demand Woes

Ecovyst

MP Materials

Sealed Air

US Goldmining Inc

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Top 5 Materials Stocks You'll Regret Missing This Quarter - Chemours (NYSE:CC), Ecovyst (NYSE:ECVT)

Kulicke & Soffa Industries

SINGAPORE , Aug. 23, 2023 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) ("Kulicke & Soffa," "K&S" or the "Company") today announced the appointment of Denise M. Dignam to its Board of Directors.

Kulicke & Soffa Appoints Denise M. Dignam to its Board of Directors

While Chemours (CC) is exposed to headwinds from demand softness in certain areas, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.

Here's Why You Should Retain Chemours (CC) in Your Portfolio

Chemours' (CC) introduction of Opteon 2P50 is a critical step in positioning the company to meet a growing challenge brought on by a new era of data transmission.

Chemours (CC) Announces Development of New Specialty Fluid

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Earns Great Place to Work Certification™ in 15 Global Regions Including the U.S.

Chemours Earns Great Place to Work Certification™ in 15 Global Regions Including the U.S.

NASHVILLE, Tenn.--(BUSINESS WIRE)--PureTech Scientific LLC today announced the completion of its acquisition of the Glycolic Acid business from The Chemours Company (NYSE: CC) for $137 million in cash, making PureTech Scientific a global leader in the organic synthesis of ultra-high purity alpha hydroxy acids for the Life Sciences and Specialty Chemical industries. PureTech Scientific was founded and backed by Iron Path Capital, a private equity firm specializing in lower-middle market investme.

Iron Path Capital-backed PureTech Scientific Completes Acquisition of Glycolic Acid Business from The Chemours Company

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million.

Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, recently announced important achievements in the development and manufacture of Opteon™ 2P50, a new heat-transfer fluid for two-phase immersion cooling (2-PIC). The proprietary fluid is currently in the final testing stages for manufacturing capability, with ini.

Chemours Announces Development of New Specialty Fluid for Two-Phase Immersion Cooling: Opteon™ 2P50

Chemours' (CC) Titanium Technologies sales were hurt by lower volumes due to weaker demand in all regions in Q2.

Chemours (CC) Q2 Earnings Beat, Titanium Technologies Hurt Sales

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the second quarter 2023 paired with the announcement of the closing of the Kuan Yin, Taiwan titanium dioxide manufacturing facility. Second Quarter 2023 Results & Highlights Ne.

The Chemours Company Reports Second Quarter 2023 Results and Announces Closure of Titanium Dioxide Plant in Taiwan

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Joseph Martinko as President, Thermal & Specialized Solutions (TSS), effective immediately. Martinko was appointed interim leader on June 1 and stood out as the top candidate following an internal and external search. "Joe.

Chemours Names Joseph Martinko as President, Thermal & Specialized Solutions

Slow demand recovery in the Titanium Technologies segment is expected to have weighed on Chemours' (CC) performance in the second quarter.

Will Titanium Technologies Unit Hurt Chemours (CC) Q2 Earnings?

Honeywell

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, and Honeywell (NASDAQ: HON), today announced they have engaged with the Interagency for Market Control of the Hellenic Ministry of Development (DIMEA), the Hellenic Police, and Hellenic Customs to stop illegal fluorinated gas (F-gas) refrigerants from entering t.

Chemours and Honeywell Partner With Authorities in the European Union to Stop Illegal Refrigerant Imports in Greece

Chemours (CC) benefits from strong Opteon demand, effective execution, and its cost-reduction and pricing actions.

Chemours (CC) Scales 52-Week High: What's Driving the Stock?

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it will release second quarter 2023 financial results after market close on July 27, 2023. The company will conduct its second quarter 2023 webcast conference call on Friday, July 28, 2023, at 8:00 a.m. Eastern Daylight Time. To allow for more Q&A.

Chemours Announces Dates for Second Quarter 2023 Earnings Release and Webcast Conference Call

Shares of Chemours Co. CC, +2.79% dropped nearly 2% in the aftermarket Friday after the chemicals company, alongside DuPont de Nemours Inc. DD, +0.82% and Corteva Inc. CTVA, -0.69%, said it has reached a final $1.85 billion deal in principle to settle claims they are responsible for so-called “forever chemicals” in drinking water in the U.S., hewing close to what the companies announced in early June. The $1.185 billion will go into a settlement fund the three companies will establish, with Chemours contributing about 50%, or about $592 million, and DuPont, with about $400 million, and Corteva, with about $193 million, contributing the remaining 50%.

News for Chemours Stock (CC)